| NCT Number | NCT05604430 |
| Lead Sponsor | Zoll Medical Corporation |
| Conditions | Altered Mental Status, Sepsis, Heart Failure, Hemorrhage, Respiratory Distress Syndrome, Adult, Cardiac Arrest |
| Enrollment | 500 participants |
| Start Date | 2022-06-30 |
| Primary Completion | 2030-04-30 (estimated) |
| Study Completion | 2030-04-30 (estimated) |
| Updated on ClinicalTrials.gov | 2025-08-17 |